Literature DB >> 11394038

Slow transit constipation.

A E Bharucha1, S F Phillips.   

Abstract

Slow transit constipation is a clinical syndrome predominantly affecting young women, characterized by constipation and delayed colonic transit, occasionally associated with pelvic floor dysfunction. The disorder spans a spectrum of variable severity, ranging from patients who have relatively mild delays in transit but who are otherwise indistinguishable from irritable bowel syndrome patients at one extreme, to patients with colonic inertia or chronic megacolon at the other extreme. Potential mechanisms for impaired colonic propulsion include fewer colonic HAPCs or a reduced colonic contractile response to a meal. The cause of the syndrome is unclear. The treatment is primarily medical; surgery is reserved for patients with severe disease or colonic inertia. Recognition and treatment of pelvic floor dysfunction is crucial for patients treated medically or surgically. Collaborative studies are necessary to determine the pathophysiology of this disorder and to ascertain the efficacy of novel prokinetic agents.

Entities:  

Mesh:

Year:  2001        PMID: 11394038     DOI: 10.1016/s0889-8553(05)70168-0

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  13 in total

Review 1.  Slow transit constipation: a functional disorder becomes an enteric neuropathy.

Authors:  Gabrio Bassotti; Vincenzo Villanacci
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

Review 2.  Normal aspects of colorectal motility and abnormalities in slow transit constipation.

Authors:  Gabrio Bassotti; Giuseppe de Roberto; Danilo Castellani; Luca Sediari; Antonio Morelli
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

3.  Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single doses.

Authors:  Kunwar Shailubhai; Stephen Comiskey; John A Foss; Rong Feng; Laura Barrow; Gail M Comer; Gary S Jacob
Journal:  Dig Dis Sci       Date:  2013-04-27       Impact factor: 3.199

4.  Sacral nerve stimulation with appropriate parameters improves constipation in rats by enhancing colon motility mediated via the autonomic-cholinergic mechanisms.

Authors:  Zhihui Huang; Shiying Li; Robert D Foreman; Jieyun Yin; Ning Dai; Jiande D Z Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-08-14       Impact factor: 4.052

5.  Intestinal gas retention in patients with idiopathic slow-transit constipation.

Authors:  Ana Cristina Hernando-Harder; Andreas Franke; Thilo Wedel; Martina Böttner; Heinz-Juergen Krammer; Manfred Vincenz Singer; Hermann Harder
Journal:  Dig Dis Sci       Date:  2007-03-24       Impact factor: 3.199

Review 6.  Update on the management of constipation in the elderly: new treatment options.

Authors:  Satish S C Rao; Jorge T Go
Journal:  Clin Interv Aging       Date:  2010-08-09       Impact factor: 4.458

7.  Treatment of Severe and Intractable Constipation.

Authors:  Adil E. Bharucha
Journal:  Curr Treat Options Gastroenterol       Date:  2004-08

8.  Overexpression of progesterone receptor B increases sensitivity of human colon muscle cells to progesterone.

Authors:  Ling Cheng; Victor Pricolo; Piero Biancani; Jose Behar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09       Impact factor: 4.052

Review 9.  Opioid-induced bowel dysfunction: pathophysiology and management.

Authors:  Christina Brock; Søren Schou Olesen; Anne Estrup Olesen; Jens Brøndum Frøkjaer; Trine Andresen; Asbjørn Mohr Drewes
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546

10.  Pilot study of pyridostigmine in constipated patients with autonomic neuropathy.

Authors:  Adil E Bharucha; Phillip A Low; Michael Camilleri; Duane Burton; Tonette L Gehrking; Alan R Zinsmeister
Journal:  Clin Auton Res       Date:  2008-07-11       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.